1401461-98-0

Upstream product

• 269409-73-6 3-carboxyphenylboronic acid pinacol ester 
• 27492-84-8 Methyl 4-amino-2-methoxybenzoate 

Downstream Products

• 1415694-78-8 2-methoxy-4-(3-(8-(6-(2-methylpyrrolidin-1-yl)pyridin-2-ylamino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl)benzamido)benzoic acid hydrochloride 
• 1415695-23-6 Methyl 2-methoxy-4-(3-(8-(6-(2-methylpyrrolidin-1-yl)pyridin-2-ylamino)-[1,2,4]-triazolo[1,5-a]pyridin-6-yl)benzamido)benzoate 
• 1415694-99-3 Methyl-4-(3-(8-bromo-[1,2,4]-triazolo[1,5-a]pyridin-6-yl)benzamido)-2-methoxybenzoate 
• 1415695-00-9 Methyl-4-(3-(8-(5,6-dimethoxypyridin-2-ylamino)-[1,2,4]-triazolo[1,5-a]pyridin-6-yl)benzamido)-2-methoxybenzoate 
• 1415694-66-4 4-{3-[8-(5,6-Dimethoxy-pyridin-2-ylamino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]-benzoylamino}-2-methoxy-benzoic acid 
• 1401461-21-9 4-(3-(7-(3,4-dimethoxyphenylamino)thiazolo[5,4-d]pyrimidin-5-yl)benzamido)-2-methoxybenzoic acid 

Relevant academic research and scientific papers

THIAZOLOPYRIMIDINE COMPOUNDS

The present invention relates to the use of novel pyrrolopyrazine derivatives of formula I: wherein all variable substituents are defined as described herein, which are SYK inhibitors and are useful for the treatment of auto-immune and inflammatory diseases.

THIAZOLOPYRIMIDINE COMPOUNDS

The present invention relates to the use of novel pyrrolopyrazine derivatives of formula I: wherein all variable substituents are defined as described herein, which are SYK inhibitors and are useful for the treatment of auto-immune and inflammatory diseases.

TRIAZOLOPYRIDINE COMPOUNDS

The present invention relates to the use of novel triazolopyridine derivatives of formula I: wherein all variable substituents are defined as described herein, which are SYK inhibitors and are useful for the treatment of auto-immune and inflammatory diseases.

TRIAZOLOPYRIDINE COMPOUNDS

The present invention relates to the use of novel triazolopyridine derivatives of formula I: wherein all variable substituents are defined as described herein, which are SYK inhibitors and are useful for the treatment of auto-immune and inflammatory diseases.